Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
468.08
-4.63 (-0.98%)
Mar 18, 2026, 11:50 AM EDT - Market open

Thermo Fisher Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21 Jul '21 Apr '21
Net Income
1,9701,6211,6191,5111,8241,6291,5541,3311,6061,6951,3621,2921,5741,4981,6682,2201,6591,9031,8292,337
Depreciation & Amortization
728661686705742739791836839853855859848838836859683628660621
Stock-Based Compensation
8470817579688470616774767577777877515151
Other Adjustments
229-10-259-14452-303-250-200-506-192-3335-52-109-191-80376116-88.5290
Changes in Other Operating Activities
--104-726-1,425-30-216-787--9-718-1,533--367-849-875-237-126-1,321
Operating Cash Flow
3,4572,2391,3997233,2902,1661,9601,2513,7232,4141,5407293,4871,9371,5282,2022,4572,6502,2271,978
Operating Cash Flow Growth
5.08%3.37%-28.62%-42.21%-11.63%-10.27%27.27%71.60%6.77%24.63%0.78%-66.89%41.92%-26.91%-31.39%11.33%-26.41%-2.14%18.08%455.62%
Capital Expenditures
-465-404-294-362-480-272-301-347-405-332-284-458-550-547-506-640-831-524-540-628
Sale of Property, Plant & Equipment
2741121720164116646641221142.55
Purchases of Investments
-32-40-47-264-1,331-287-20-1,758-8-12-186-2--------
Proceeds from Sale of Investments
1,311---1,761---------------
Payments for Business Acquisitions
---------454.5-909-47-2,7040.51-20-40-17,876-94-82-1,343
Other Investing Activities
5198528843945271116-831619-37584-2-4-32
Investing Cash Flow
891-4,123-288-52720-3,578-253-2,030-376-1,181-443-3,142-525-545-419-670-18,692-616-626-1,998
Short-Term Debt Issued
----------5931,0272951994066262,5121,256--
Short-Term Debt Repaid
-498--------247-494-918-5235,216-200-2,231-1,259----
Net Short-Term Debt Issued (Repaid)
-498--------247-494-3255045,511-1-1,825-6332,5121,256--
Long-Term Debt Issued
4,9192,4601,4202,840---11,2052,4763,466--3,193---15,015---
Long-Term Debt Repaid
-787-393.5-787-838-2,500-1,107---3,782-1,000-500----187.5-375-8,935-4,468-1,402-2,803
Net Long-Term Debt Issued (Repaid)
4,1322,0666332,002-2,500-1,107-11,205-1,3062,466-500-3,193--187.5-3756,080-4,468-1,402-2,803
Issuance of Common Stock
-----------------295220
Repurchase of Common Stock
-37-963-1,000-2,000-1,000-500-1,500-3,000---1,500-3,000-1,690-845-1,000-2,000---1,000-2,000
Net Common Stock Issued (Repurchased)
-37-963-1,000-2,000-1,000-500-1,500-3,000---1,500-3,000-1,690-845-1,000-2,000-29-948-1,980
Common Dividends Paid
-162-163-162-149-149-150-149-135-136-135-135-117-117-118-117-103-103-102-103-87
Other Financing Activities
91-4-4245-176735110141842077-3237-3479-9-2520
Financing Cash Flow
3,526-632-991-102-3,666-1,190-115-1,821-1,4281,855-1,456-2,5932,391-151-1,905-3,1458,4673,040-76-4,850
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-6-7531137-273175-152210-7312-31250-212-78-99211-61-93137
Net Cash Flow
7,868-2,591431131-629-2,4271,577-2,5781,9293,015-347-5,0375,6031,029-874-1,712-7,5575,0131,432-4,733
Free Cash Flow
2,9921,8351,1053612,8101,8941,6599043,3182,0821,2562712,9371,3901,0221,5621,6262,1261,6871,350
Free Cash Flow Growth
6.48%-3.12%-33.39%-60.07%-15.31%-9.03%32.09%233.58%12.97%49.78%22.90%-82.65%80.63%-34.62%-39.42%15.70%-40.94%-9.22%4.33%1210.68%
FCF Margin
24.49%16.50%10.18%3.48%24.66%17.87%15.74%8.74%30.48%19.69%11.75%2.53%25.65%13.02%9.32%13.22%15.19%22.79%18.19%13.63%
Free Cash Flow Per Share
7.944.852.920.957.344.934.332.358.555.373.240.707.473.522.593.954.095.364.263.40
Levered Free Cash Flow
5,8613,8351,9162,427-4081,0201,8212,2355114,19938966110,5781,418-867.555110,102-968.5420.5-1,794
Unlevered Free Cash Flow
2,3551,8741,401532.492,1252,2301,9551,0752,1462,3191,373377.261,9751,5991,2701,8282,1132,3351,9261,260
Updated Jan 29, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q